Magnesium ions and opioid agonists in vincristine-induced neuropathy

Pharmacological Reports

Volumn 61, Issue 6, 2009, Pages 1096-1104

  Bujalska, Magdalena ^a   Makulska Nowak, Helena ^a   Gumułka, Stanisław W ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Chemotherapy; Hyperalgesia; Magnesium ions; Neuropathy; Opioids; Rats; Vincristine

Indexed keywords

BUPRENORPHINE; FENTANYL; MAGNESIUM ION; MAGNESIUM SULFATE; MORPHINE; OPIATE ANTAGONIST; VINCRISTINE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG MECHANISM; HYPERALGESIA; MALE; MECHANICAL STIMULATION; NEUROPATHIC PAIN; NONHUMAN; RAT;

EID: 76049114530     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70172-0     Document Type: Article

References (30)

1. Aley KO, Reichling DB, Levine JD: Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans. Neuroscience, 1996, 73, 259-265.
2. Arnér S, Meyerson BA: Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain, 1988, 33, 11-23.
3. Begon S, Pickering G, Eschalier A, Dubray C: Magnesium increases morphine analgesic effect in different experimental models of pain. Anesthesiology, 2002, 96, 627-632.
4. Bolcal C, Iyem H, Sargin M, Mataraci I, Yildirim V, Doganci S, Ozal E, Demirkilic U, Tatar H: Comparison of magnesium sulfate with opioid and NSAIDs on post-operative pain management after coronary artery bypass surgery. J Cardiothorac Vasc Anesth, 2005, 19, 714-718.
5. Bordi F, Quartaroli M: Modulation of nociceptive transmission by NMDA/glycine site receptor in the ventroposterolateral nucleus of the thalamus. Pain, 2000, 84, 213-224.
6. 2 -Adrenoreceptor antagonists in streptozotocin-and vincristine-induced hyperalgesia. Pharmacol Rep, 2008, 60, 499-507.
7. Bujalska M, Malinowska E, Makulska-Nowak H, Gumułka SW: Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia. Pharmacology, 2008, 82, 180-186.
8. Christensen D, Gautron M, Guilbaud G, Kayser V: Combined systemic administration of the glycine/NMDA receptor antagonist, (+)-HA966 and morphine attenuates pain-related behaviour in a rat of trigeminal neuropathic pain. Pain, 1999, 83, 433-440.
9. Courteix C, Bardin M, Chantelauze C, Laverenne J, Eschalier A: Study of the sensitivity of the diabetesinduced pain model in rats to a range of analgesics. Pain, 1994, 57, 153-160.
10. Crosby V, Wilcock A, Corcoran R: The safety and efficacy of a single dose (500 mg or 1g) of intravenous magnesium sulfate in neuropathic pain poorly responsive to strong opioid analgesics in patients with cancer. J Pain Symptom Manage, 2000, 19, 35-39.
11. Dellemijn P: Are opioids effective in relieving neuropathic pain? Pain, 1999, 80, 453-462.
12. Dickenson AH: NMDA receptor antagonists: interactions with opioids. Acta Anaesthesiol Scan, 1997, 41, 112-115.
13. Ebert B, Thorkildsen C, Andersen S, Christrup LL, Hjeds H: Opioid analgesics as noncompetitive Nmethyl-D-aspartate (NMDA) antagonists. Biochem Pharmacol, 1998, 56, 553-559.
14. Feria M, Abad F, Sánchez A, Abreu P: Magnesium sulphate injected subcutaneously suppresses autotomy in peripherally deafferented rats. Pain, 1993, 53, 287-293.
15. Ishizaki K, Sasaki M, Karasawa S, Obata H, Nara T, Goto F: The effect of intrathecal magnesium sulphate on nociception in rat acute pain models. Anaesthesia, 1999, 54, 241-246.
16. Kroin JS, McCarthy RJ, Von Roenn N, Schwab B, Tuman KJ, Ivankovich AD: Magnesium sulfate potentiates morphine antinociception at the spinal level. Anesth Analg, 2000, 90, 913-917.
17. Malyshkin AA, Medvedev IO, Danysz W, Bespalov AY: Anti-allodynic interactions between NMDA receptor channel blockers and morphine or clonidine neuropathic rats. Eur J Pharmacol, 2005, 519, 80-85.
18. Mao J, Donald D, Mayer P, Mayer DJ: Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain, 1995, 61, 353-364.
19. McCarthy RJ, Kroin JS, Tuman KJ, Penn RD, Ivankovich AD: Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats. Anesth Analg, 1998, 86, 830-836.
20. Nichols ML, Lopez Y, Ossipov MH, Bian D, Porreca F: Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A (1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy. Pain, 1997, 69, 317-322.
21. Özalevli M, Cetin TO, Unlugenc H, Guler T, Isik G: The effect of adding intrathecal magnesium sulphate to bupivacaine-fentanyl spinal anaesthesia. Acta Anaesthesiol Scand, 2005, 49, 1514-1519.
22. Parsons CG: NMDA receptors as targets for drug action in naturopathic pain. Eur J Pharmacol, 2001, 429, 71-78.
23. Randall LO, Selitto JJ: A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther, 1957, 111, 409-419.
24. Tallarida RJ, Murray RB: Manual of Pharmacologic Calculation with Computer Programs (ed 2): New York, Springer, 1986, 113-117.
25. Taracha E, Lehner M, Wisłowska-Stanek A, Zienowicz M, Maciejak P, Bidziński A, Skórzewska A et al.: Effects of methadone and morphine on c-Fos expression in the rat brain: similarities and differences. Pharmacol Rep, 2006, 58, 120-124.
26. Tramer MR, Schneider J, Marti RA, Rifat K: Role magnesium sulfate in postoperative analgesia. Anesthesiology, 1996, 84, 340-347.
27. Ulugol A, Aslantas A, Ipci Y, Tuncer A, Karadag CH, Dokmeci I: Combined systemic administartion of morphine and magnesium sulfate attenuates pain-related behavior in mononeuropathic rats. Brain Research, 2002, 943, 101-104.
28. Yamakura T, Sakimura K, Shimoji K: Direct inhibition of the N-methyl-D-aspartate receptor channel by high concentrations of opioids. Anesthesiology, 1999, 91, 1053-1063.
29. Yamamoto T, Yaksh TL: Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy. Neurosci Lett, 1992, 135, 67-70.
30. Zurek JR, Nadeson R, Goodchild CS: Spinal and supraspinal components of opioid antinociception in streptozotocin induced diabetic neuropathy in rats. Pain, 2001, 90, 57-63.